tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ALVO Stock Latest News

Alvotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
Press ReleasesAlvotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
27d ago
ALVO
Alvotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
PremiumPress Releases
Alvotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
27d ago
ALVO
Alvotech files to sell 1.79M ordinary shares for holders
PremiumThe Fly
Alvotech files to sell 1.79M ordinary shares for holders
1M ago
ALVO
Alvotech Reports Revenue Surge Amidst Expansion
PremiumCompany Announcements
Alvotech Reports Revenue Surge Amidst Expansion
1M ago
6K
ALVO
Alvotech’s Biosimilar AVT06 Eyes European Market
PremiumCompany Announcements
Alvotech’s Biosimilar AVT06 Eyes European Market
1M ago
6K
ALVO
European Medicines Agency Confirms Acceptance of Marketing Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)
PremiumPress ReleasesEuropean Medicines Agency Confirms Acceptance of Marketing Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)
1M ago
ALVO
European Medicines Agency Confirms Acceptance of Marketing Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)
Premium
Press Releases
European Medicines Agency Confirms Acceptance of Marketing Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)
1M ago
ALVO
Alvotech to Report Financial Results for the First Half of 2024 on August 15, 2024, and Host Conference Call on August 16, 2024, at 8:00 am ET
Premium
Press Releases
Alvotech to Report Financial Results for the First Half of 2024 on August 15, 2024, and Host Conference Call on August 16, 2024, at 8:00 am ET
2M ago
ALVO
Alvotech to Report Financial Results for the First Half of 2024 on August 15, 2024, and Host Conference Call on August 16, 2024, at 8:00 am ET
PremiumPress Releases
Alvotech to Report Financial Results for the First Half of 2024 on August 15, 2024, and Host Conference Call on August 16, 2024, at 8:00 am ET
2M ago
ALVO
Alvotech price target lowered to $18 from $22 at Barclays
PremiumThe Fly
Alvotech price target lowered to $18 from $22 at Barclays
2M ago
ALVO
Alvotech Launches First Stelara Biosimilar in Europe
PremiumCompany Announcements
Alvotech Launches First Stelara Biosimilar in Europe
2M ago
6K
ALVO
STADA and Alvotech launch Uzpruvo, the first approved ustekinumab biosimilar to Stelara, across Europe
PremiumPress Releases
STADA and Alvotech launch Uzpruvo, the first approved ustekinumab biosimilar to Stelara, across Europe
2M ago
ALVO
STADA and Alvotech launch Uzpruvo, the first approved ustekinumab biosimilar to Stelara, across Europe
PremiumPress ReleasesSTADA and Alvotech launch Uzpruvo, the first approved ustekinumab biosimilar to Stelara, across Europe
2M ago
ALVO
Alvotech Secures $965M for Growth and Refinancing
Premium
Company Announcements
Alvotech Secures $965M for Growth and Refinancing
2M ago
6K
ALVO
Alvotech Announces Closing of Private Debt Financing
Premium
Press Releases
Alvotech Announces Closing of Private Debt Financing
2M ago
ALVO
Alvotech Announces Closing of Private Debt Financing
PremiumPress Releases
Alvotech Announces Closing of Private Debt Financing
2M ago
ALVO
Alvotech’s AVT03 Shows Promising Study Results
PremiumCompany Announcements
Alvotech’s AVT03 Shows Promising Study Results
3M ago
6K
ALVO
Alvotech announces results from confirmatory patient study for AVT03
PremiumThe Fly
Alvotech announces results from confirmatory patient study for AVT03
3M ago
ALVO
Alvotech Announces Positive Topline Results from Confirmatory Patient Study for AVT03, a Proposed Biosimilar for Prolia® and Xgeva®
PremiumPress Releases
Alvotech Announces Positive Topline Results from Confirmatory Patient Study for AVT03, a Proposed Biosimilar for Prolia® and Xgeva®
3M ago
ALVO
Alvotech Announces Positive Topline Results from Confirmatory Patient Study for AVT03, a Proposed Biosimilar for Prolia® and Xgeva®
PremiumPress ReleasesAlvotech Announces Positive Topline Results from Confirmatory Patient Study for AVT03, a Proposed Biosimilar for Prolia® and Xgeva®
3M ago
ALVO
Alvotech Expands Share Count with Bond Conversion
Premium
Company Announcements
Alvotech Expands Share Count with Bond Conversion
3M ago
6K
ALVO
Alvotech Issues New Shares to Holders of Convertible Bonds
Premium
Press Releases
Alvotech Issues New Shares to Holders of Convertible Bonds
3M ago
ALVO

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >